Biomarkers
Test 147. Prognostic markers in tumors of the central nervous system
Test 148. Prognostic markers in tumors of the central nervous system
Test 149. Prognostic markers in tumors of the central nervous system
Test 151. Diagnostic markers for tumors in the central nervous system, endometrium, stomach, and others
Test 152. Diagnostic and prognostic markers in brain, PNET, thyroid and other tumors
Test 153. Diagnostic and prognostic markers in brain, PNET, thyroid and other tumors
Test 154. Diagnostic and prognostic markers in brain, PNET, thyroid and other tumors
Test 155. Diagnostic marker for the presence of DICER1 syndrome
Test 156. Diagnostic and Predictive Markers for Targeted Therapy in Gastrointestinal Stromal Tumor (GIST)
Test 157. Diagnostic and Predictive Markers for Targeted Therapy in Gastrointestinal Stromal Tumor (GIST)
Test 158. Diagnostic and Predictive Markers for Targeted Therapy in Gastrointestinal Stromal Tumor (GIST)
Test 159. Diagnostic and Predictive Markers for Targeted Therapy in Gastrointestinal Stromal Tumor (GIST)
Test 160. Predictive marker BRAF (V600) mutations for targeted therapy in oncological diseases (melanoma, colorectal and lung carcinomas, thyroid gland, GIST, brain tumors, etc.)
Test 161. Predictive marker for targeted therapy in chronic lymphocytic leukemia (CLL)
Test 162. Predictive marker for targeted therapy in chronic lymphocytic leukemia (CLL)
Test 163. Optimizing therapy with the indirect anticoagulant acenocoumarol (Syntrom)
Test 164. Optimizing therapy with the antiplatelet agent clopidogrel (Plavix)
Test 165. Optimization of methotrexate therapy
Test 166. Optimizing Isoniazid for the treatment of pulmonary tuberculosis
Test 167. Investigation of DPYD variants to optimize chemotherapy with 5-fluorouracil and capecitabine
Test 168. Minimal residual disease in patients with neuroblastoma
Test 169. Optimizing therapy with drugs from the thiopurine group (Azathioprine, Mercaptopurine and Thioguanine)
Test 170. Optimizing therapy with drugs from the thiopurine group (Azathioprine, Mercaptopurine and Thioguanine)
Test 171. Slow metabolizers by CYP2C9
Test 172. Slow metabolizers by CYP2C19
Test 173. Slow metabolizers by CYP2D6
Test 174. Diagnostic markers in brain, rhabdoid, solid and other tumors
Test 175. Diagnostic markers in brain, rhabdoid, solid and other tumors
Test 176. Carrier Analysis of Variants Associated with Reproductive Disadvantages
Test 177. Carrier Analysis of Variants Associated with Reproductive Disadvantages
Test 179. Analysis of gene pannel associated with targeted therapy in solid tumors and interpretation
Categories
Inherited Oncological Diseases
Rare Diseases
Clinical Exome
Prenatal Diagnostics
Neurological and Neurodegenerative Diseases
Ocular and Ear Diseases
Kidney and Cardiovascular Diseases
Biomarkers
Congenital Аnomalies
Mitochondrial and Metabolic Diseases
Connective Tissue Diseases
Endocrinological Diseases